fact is POZN is the BEST bio tech investment at this moment
Look at AFFY and at SPPI and at many many others. POZN has NO DEBT, a HUGE CASH position, has a good reputation in finding a good deal....and the drug will replace ASPERIN, the most taken drug in the world !!!! And VIMOVO is NOT played out yet !!!! With the stockk market at an all time high, which often anounces a huge pull back.... POZN is very cheap at $6
You are right. Look at the daily volume for the past three, four weeks, a huge increased volume due to the hedge fund managers are accumulating shares every day. I think the stock price of POZN may have a big jump happens any time within three weeks from now on.
PLachetka said they will have a partner before the end of quarter 2. YOu can already guess waht will happen. And the deal will be much more worth because they developed everything by themselves. Before,with Treximet and Vimovo , POZN got around 10% of the NET revenues, not much but GSK and AZ payed all the bills. But this time, POZN payed everything... so when there is a deal it will be more like a 50%. YOu can ask yourself why POZN needs a partner, but they DO NEED. The worse thing that a bio tech can do is trying to distribute a new drug by themselves !!!! Distributing a drug is a very VERY VERY expensive and complicated thing that best can be done by specialists. And that is what Plachetka is looking for. A partner who can do that job for free and leaving 50% on the table for POZN. And in my opinion.... a replacer for Asperine... will be a blockbuster within a few years, if distributed in a good way. And with only 30 million shares, no debts, $80 million cash and a steady income from Vimovo..... no, I do not know ANY bio tech who has all this.... I expêct we will see +50% soon